PRESSURE BIOSCIENC : Pressure BioSciences, Inc. to Discuss Third Quarter 2008 Financial Results and Provide Business Update
11/14/2008| 04:15pm US/Eastern
SOUTH EASTON, Mass., Nov. 14 /PRNewswire-FirstCall/ -- Pressure
BioSciences, Inc. (Nasdaq: PBIO) today announced that the Company will host a
teleconference to discuss its third quarter 2008 financial results and to
provide a business update. Anyone interested may listen to the teleconference
either by telephone or through a live web-cast. The teleconference and
web-cast information is provided below:
Date: Monday, November 17, 2008
Time: 4:30 p.m. Eastern Standard Time (EST)
To attend this teleconference via web-cast, please go to the Company's
To attend this teleconference via telephone:
Dial-in: (800) 344-6491
Participant code: 3034253
For those unable to participate in the live teleconference, a replay will
be available approximately one hour after the call ends, and will be
accessible through the Company's website.
About Pressure BioSciences, Inc.
Pressure BioSciences, Inc. (PBI) is a publicly-traded company focused on
the development of a novel, enabling technology called Pressure Cycling
Technology (PCT). PCT uses cycles of hydrostatic pressure between ambient and
ultra-high levels (up to 35,000 psi and greater) to control bio-molecular
interactions. PBI currently holds 13 US and 6 foreign patents covering
multiple applications of PCT in the life sciences' field, including such areas
as genomic and proteomic sample preparation, pathogen inactivation, the
control of chemical reactions, immunodiagnostics, and protein purification.
Richard T. Schumacher, President & CEO
Edward H. Myles, Senior Vice President of Finance & CFO
Pressure BioSciences, Inc.
SOURCE Pressure BioSciences, Inc.